Serveur d'exploration sur le patient édenté

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Decreased bone mineral density and periodontal management

Identifieur interne : 002C86 ( Main/Exploration ); précédent : 002C85; suivant : 002C87

Decreased bone mineral density and periodontal management

Auteurs : Michael S. Reddy ; Sarah L. Morgan

Source :

RBID : ISTEX:CAC7376825EFAC7359D65DDB961BC8531EDDA150

Descripteurs français

English descriptors

Abstract

The definition of osteoporosis has evolved beyond low bone mineral density to include impaired bone morphology and matrix properties. As such, the subsequent bone density insufficiencies extend beyond the skeletal risks of fracture and have implications for oral health management patients. As our population ages there is a worldwide increase in the risk of decreased bone mineral density and its subsequent morbidity. This makes age an independent risk factor for fracture and decreased bone mineral density. Multiple examinations and diagnostic tests are currently used in combination to develop an algorithm to assess osteoporotic risk. Oral health care professionals should follow these principles and caution should be used in applying a single independent assessment to determine a patient's osteoporotic or bone metabolism risk. Therapeutic approaches for osteoporosis are often divided into nonpharmacological interventions and pharmacological therapies. The periodontist and other oral health care professionals should have a full understanding of the therapeutic options, benefits and implementation of preventive therapies. Bone turnover is a coupled event of bone formation and bone resorption and it is the imbalance of this homeostasis that results in osteoporosis. Based on this uncoupling of bone resorption and formation, osteoporosis or decreased bone mineral density and osteopenia, may be a risk factor for alveolar bone loss in periodontitis. The role of prevention and maintenance with a history of periodontitis and oesteopenia extends beyond biofilm control and should include management of bone mineral density. The chronic periodontal infection in a patient with osteopenia may place the patient at greatly increased risk for alveolar bone loss, gingival recession and root caries. A key component in the management is the oral health professional's knowledge of the interrelationship between skeletal health and periodontal health.

Url:
DOI: 10.1111/j.1600-0757.2011.00400.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Decreased bone mineral density and periodontal management</title>
<author>
<name sortKey="Reddy, Michael S" sort="Reddy, Michael S" uniqKey="Reddy M" first="Michael S." last="Reddy">Michael S. Reddy</name>
</author>
<author>
<name sortKey="Morgan, Sarah L" sort="Morgan, Sarah L" uniqKey="Morgan S" first="Sarah L." last="Morgan">Sarah L. Morgan</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:CAC7376825EFAC7359D65DDB961BC8531EDDA150</idno>
<date when="2013" year="2013">2013</date>
<idno type="doi">10.1111/j.1600-0757.2011.00400.x</idno>
<idno type="url">https://api.istex.fr/document/CAC7376825EFAC7359D65DDB961BC8531EDDA150/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">006481</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">006481</idno>
<idno type="wicri:Area/Istex/Curation">006481</idno>
<idno type="wicri:Area/Istex/Checkpoint">000839</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000839</idno>
<idno type="wicri:doubleKey">0906-6713:2013:Reddy M:decreased:bone:mineral</idno>
<idno type="wicri:Area/Main/Merge">002C98</idno>
<idno type="wicri:Area/Main/Curation">002C86</idno>
<idno type="wicri:Area/Main/Exploration">002C86</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Decreased bone mineral density and periodontal management</title>
<author>
<name sortKey="Reddy, Michael S" sort="Reddy, Michael S" uniqKey="Reddy M" first="Michael S." last="Reddy">Michael S. Reddy</name>
</author>
<author>
<name sortKey="Morgan, Sarah L" sort="Morgan, Sarah L" uniqKey="Morgan S" first="Sarah L." last="Morgan">Sarah L. Morgan</name>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Periodontology 2000</title>
<title level="j" type="alt">PERIODONTOLOGY 2000</title>
<idno type="ISSN">0906-6713</idno>
<idno type="eISSN">1600-0757</idno>
<imprint>
<biblScope unit="vol">61</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="195">195</biblScope>
<biblScope unit="page" to="218">218</biblScope>
<biblScope unit="page-count">24</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2013-02">2013-02</date>
</imprint>
<idno type="ISSN">0906-6713</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0906-6713</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Alendronate</term>
<term>Alveolar bone</term>
<term>Alveolar bone loss</term>
<term>American menopause society</term>
<term>Assoc</term>
<term>Bisphosphonate</term>
<term>Bisphosphonates</term>
<term>Bone</term>
<term>Bone density</term>
<term>Bone formation</term>
<term>Bone loss</term>
<term>Bone mass</term>
<term>Bone mass measurement</term>
<term>Bone miner</term>
<term>Bone mineral density</term>
<term>Bone resorption</term>
<term>Bone strength</term>
<term>Bone turnover</term>
<term>Brand name</term>
<term>Breast cancer</term>
<term>Calcitonin</term>
<term>Calcium</term>
<term>Calcium absorption</term>
<term>Calcium carbonate</term>
<term>Calcium citrate</term>
<term>Calcium supplements</term>
<term>Carbonate</term>
<term>Caucasian</term>
<term>Cauley</term>
<term>Cervical lesions</term>
<term>Chesnut</term>
<term>Chronic periodontitis</term>
<term>Citrate</term>
<term>Clin</term>
<term>Clin densitom</term>
<term>Clin endocrinol metab</term>
<term>Clinical densitometry</term>
<term>Common osteoporotic fracture</term>
<term>Cummings</term>
<term>Cytokine</term>
<term>Delmas</term>
<term>Denosumab</term>
<term>Dent</term>
<term>Dental implants</term>
<term>Drug administration</term>
<term>East hanover</term>
<term>Economic burden</term>
<term>Edentulous</term>
<term>Edentulous patients</term>
<term>Engl</term>
<term>Epidemiology</term>
<term>Estrogen</term>
<term>Estrogen therapy</term>
<term>Fall prevention</term>
<term>Femoral neck</term>
<term>Fracture</term>
<term>Fracture rates</term>
<term>Fracture risk</term>
<term>Fracture trial</term>
<term>Gingival</term>
<term>Gingival recession</term>
<term>Growth factors</term>
<term>Health initiative</term>
<term>Health initiative investigators</term>
<term>Healthcare</term>
<term>Height loss</term>
<term>Hormone replacement therapy</term>
<term>Ibandronate</term>
<term>Implant</term>
<term>Increase bone mineral density</term>
<term>International society</term>
<term>Intravenous bisphosphonates</term>
<term>Jeffcoat</term>
<term>Lesion</term>
<term>Lumbar spine</term>
<term>Mandible</term>
<term>Mandibular</term>
<term>Matrix</term>
<term>Maxillofac</term>
<term>Medication</term>
<term>Menopause</term>
<term>Metab</term>
<term>Metabolic bone disease</term>
<term>Miner</term>
<term>Mineral</term>
<term>National osteoporosis foundation</term>
<term>Nuclear factor</term>
<term>Oral bisphosphonates</term>
<term>Oral bone loss</term>
<term>Oral infection</term>
<term>Oral maxillofac surg</term>
<term>Osteoblast</term>
<term>Osteoclast</term>
<term>Osteoclast activity</term>
<term>Osteoclast formation</term>
<term>Osteonecrosis</term>
<term>Osteopenia</term>
<term>Osteoporos</term>
<term>Osteoporosis</term>
<term>Osteoporotic</term>
<term>Osteoporotic fractures</term>
<term>Osteoprogenitor cells</term>
<term>Parathyroid</term>
<term>Parathyroid hormone</term>
<term>Periodontal</term>
<term>Periodontal bone loss</term>
<term>Periodontal disease</term>
<term>Periodontal management</term>
<term>Periodontitis</term>
<term>Periodontol</term>
<term>Pharmacological therapies</term>
<term>Phosphorus</term>
<term>Physical examination</term>
<term>Postmenopausal</term>
<term>Postmenopausal osteoporosis</term>
<term>Postmenopausal women</term>
<term>Prosthet dent</term>
<term>Raloxifene</term>
<term>Randomized</term>
<term>Randomized trial</term>
<term>Rankl</term>
<term>Receptor</term>
<term>Receptor activator</term>
<term>Reddy</term>
<term>Reddy morgan</term>
<term>Reddy morgan table</term>
<term>Residual</term>
<term>Resorption</term>
<term>Risedronate</term>
<term>Risk factor</term>
<term>Risk factors</term>
<term>Root caries</term>
<term>Root planing</term>
<term>Screening tool</term>
<term>Secondary causes</term>
<term>Selective estrogen receptor modulators</term>
<term>Skeletal bone mineral density</term>
<term>Standard deviations</term>
<term>Supplementation</term>
<term>Surg</term>
<term>Systemic bone mineral density</term>
<term>Teriparatide</term>
<term>Therapy</term>
<term>Tooth extraction</term>
<term>Tooth loss</term>
<term>Trabecular</term>
<term>Vertebral</term>
<term>Vertebral fracture</term>
<term>Vertebral fractures</term>
<term>Vitamin</term>
<term>Warner chilcott</term>
<term>Zoledronic</term>
<term>Zoledronic acid</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Alendronate</term>
<term>Alveolar bone</term>
<term>Alveolar bone loss</term>
<term>American menopause society</term>
<term>Assoc</term>
<term>Bisphosphonate</term>
<term>Bisphosphonates</term>
<term>Bone</term>
<term>Bone density</term>
<term>Bone formation</term>
<term>Bone loss</term>
<term>Bone mass</term>
<term>Bone mass measurement</term>
<term>Bone miner</term>
<term>Bone mineral density</term>
<term>Bone resorption</term>
<term>Bone strength</term>
<term>Bone turnover</term>
<term>Brand name</term>
<term>Breast cancer</term>
<term>Calcitonin</term>
<term>Calcium</term>
<term>Calcium absorption</term>
<term>Calcium carbonate</term>
<term>Calcium citrate</term>
<term>Calcium supplements</term>
<term>Carbonate</term>
<term>Caucasian</term>
<term>Cauley</term>
<term>Cervical lesions</term>
<term>Chesnut</term>
<term>Chronic periodontitis</term>
<term>Citrate</term>
<term>Clin</term>
<term>Clin densitom</term>
<term>Clin endocrinol metab</term>
<term>Clinical densitometry</term>
<term>Common osteoporotic fracture</term>
<term>Cummings</term>
<term>Cytokine</term>
<term>Delmas</term>
<term>Denosumab</term>
<term>Dent</term>
<term>Dental implants</term>
<term>Drug administration</term>
<term>East hanover</term>
<term>Economic burden</term>
<term>Edentulous</term>
<term>Edentulous patients</term>
<term>Engl</term>
<term>Epidemiology</term>
<term>Estrogen</term>
<term>Estrogen therapy</term>
<term>Fall prevention</term>
<term>Femoral neck</term>
<term>Fracture</term>
<term>Fracture rates</term>
<term>Fracture risk</term>
<term>Fracture trial</term>
<term>Gingival</term>
<term>Gingival recession</term>
<term>Growth factors</term>
<term>Health initiative</term>
<term>Health initiative investigators</term>
<term>Healthcare</term>
<term>Height loss</term>
<term>Hormone replacement therapy</term>
<term>Ibandronate</term>
<term>Implant</term>
<term>Increase bone mineral density</term>
<term>International society</term>
<term>Intravenous bisphosphonates</term>
<term>Jeffcoat</term>
<term>Lesion</term>
<term>Lumbar spine</term>
<term>Mandible</term>
<term>Mandibular</term>
<term>Matrix</term>
<term>Maxillofac</term>
<term>Medication</term>
<term>Menopause</term>
<term>Metab</term>
<term>Metabolic bone disease</term>
<term>Miner</term>
<term>Mineral</term>
<term>National osteoporosis foundation</term>
<term>Nuclear factor</term>
<term>Oral bisphosphonates</term>
<term>Oral bone loss</term>
<term>Oral infection</term>
<term>Oral maxillofac surg</term>
<term>Osteoblast</term>
<term>Osteoclast</term>
<term>Osteoclast activity</term>
<term>Osteoclast formation</term>
<term>Osteonecrosis</term>
<term>Osteopenia</term>
<term>Osteoporos</term>
<term>Osteoporosis</term>
<term>Osteoporotic</term>
<term>Osteoporotic fractures</term>
<term>Osteoprogenitor cells</term>
<term>Parathyroid</term>
<term>Parathyroid hormone</term>
<term>Periodontal</term>
<term>Periodontal bone loss</term>
<term>Periodontal disease</term>
<term>Periodontal management</term>
<term>Periodontitis</term>
<term>Periodontol</term>
<term>Pharmacological therapies</term>
<term>Phosphorus</term>
<term>Physical examination</term>
<term>Postmenopausal</term>
<term>Postmenopausal osteoporosis</term>
<term>Postmenopausal women</term>
<term>Prosthet dent</term>
<term>Raloxifene</term>
<term>Randomized</term>
<term>Randomized trial</term>
<term>Rankl</term>
<term>Receptor</term>
<term>Receptor activator</term>
<term>Reddy</term>
<term>Reddy morgan</term>
<term>Reddy morgan table</term>
<term>Residual</term>
<term>Resorption</term>
<term>Risedronate</term>
<term>Risk factor</term>
<term>Risk factors</term>
<term>Root caries</term>
<term>Root planing</term>
<term>Screening tool</term>
<term>Secondary causes</term>
<term>Selective estrogen receptor modulators</term>
<term>Skeletal bone mineral density</term>
<term>Standard deviations</term>
<term>Supplementation</term>
<term>Surg</term>
<term>Systemic bone mineral density</term>
<term>Teriparatide</term>
<term>Therapy</term>
<term>Tooth extraction</term>
<term>Tooth loss</term>
<term>Trabecular</term>
<term>Vertebral</term>
<term>Vertebral fracture</term>
<term>Vertebral fractures</term>
<term>Vitamin</term>
<term>Warner chilcott</term>
<term>Zoledronic</term>
<term>Zoledronic acid</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Marque commerciale</term>
<term>Calcium</term>
<term>épidémiologie</term>
<term>Mineur (ouvrier)</term>
<term>Phosphore</term>
<term>Vitamine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The definition of osteoporosis has evolved beyond low bone mineral density to include impaired bone morphology and matrix properties. As such, the subsequent bone density insufficiencies extend beyond the skeletal risks of fracture and have implications for oral health management patients. As our population ages there is a worldwide increase in the risk of decreased bone mineral density and its subsequent morbidity. This makes age an independent risk factor for fracture and decreased bone mineral density. Multiple examinations and diagnostic tests are currently used in combination to develop an algorithm to assess osteoporotic risk. Oral health care professionals should follow these principles and caution should be used in applying a single independent assessment to determine a patient's osteoporotic or bone metabolism risk. Therapeutic approaches for osteoporosis are often divided into nonpharmacological interventions and pharmacological therapies. The periodontist and other oral health care professionals should have a full understanding of the therapeutic options, benefits and implementation of preventive therapies. Bone turnover is a coupled event of bone formation and bone resorption and it is the imbalance of this homeostasis that results in osteoporosis. Based on this uncoupling of bone resorption and formation, osteoporosis or decreased bone mineral density and osteopenia, may be a risk factor for alveolar bone loss in periodontitis. The role of prevention and maintenance with a history of periodontitis and oesteopenia extends beyond biofilm control and should include management of bone mineral density. The chronic periodontal infection in a patient with osteopenia may place the patient at greatly increased risk for alveolar bone loss, gingival recession and root caries. A key component in the management is the oral health professional's knowledge of the interrelationship between skeletal health and periodontal health.</div>
</front>
</TEI>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Morgan, Sarah L" sort="Morgan, Sarah L" uniqKey="Morgan S" first="Sarah L." last="Morgan">Sarah L. Morgan</name>
<name sortKey="Reddy, Michael S" sort="Reddy, Michael S" uniqKey="Reddy M" first="Michael S." last="Reddy">Michael S. Reddy</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C86 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002C86 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    EdenteV2
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:CAC7376825EFAC7359D65DDB961BC8531EDDA150
   |texte=   Decreased bone mineral density and periodontal management
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Thu Nov 30 15:26:48 2017. Site generation: Tue Mar 8 16:36:20 2022